Login / Signup

Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation.

Quirino LaiPaolo MagistriRaffaella LionettiAlfonso W AvolioIlaria LenciValerio GiannelliAnnarita PecchiFlaminia FerriGiuseppe MarroneMario AngelicoMartina MilanaVincenzo SchinnináRenata MenozziMichele Di MartinoAntonio GriecoTommaso M ManziaGiuseppe TisoneSalvatore AgnesMassimo RossiFabrizio Di BenedettoGiuseppe M Ettorrenull null
Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)
In sarcopenic patients with MELDNa < 20, the 'urgency' Sarco-Model2 should be used to prioritize the list, while MELDNa value should be preferred in patients with MELDNa ≥ 20. The Sarco-Model2 played a role in more than 30% of the cases in the investigated allocation scenario. In sarcopenic patients with a MELDNa value of 35-40, 'futile' transplantation should be considered.
Keyphrases
  • end stage renal disease
  • endoplasmic reticulum
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • stem cells
  • peritoneal dialysis
  • cell therapy
  • bone marrow
  • atomic force microscopy
  • mass spectrometry